Who Paid My Doc
Ayaz Khan
Addiction Medicine Williamsport, PA Medical Doctor
NPI 1629052188 CMS profile 163868
553 E 3Rd St, Pain Management Of Williamsport, Williamsport, PA 17701
General payments
$101
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Ayaz Khan of Williamsport, PA is reported in the CMS Open Payments database as having received $101 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $28 | 1 | |
| 2024 | General | $73 | 1 |
Beside peers
- Ayaz Khan
- Addiction Medicine median
- Middle half of Addiction Medicine
- National median
In program year 2025, general payments to Ayaz Khan were reported at $28. Among 29 Addiction Medicine profiles paid that year, the median was $133 and the middle half received between $46 and $264.
Show as a table
| Year | Ayaz Khan | Addiction Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $59 | $32–$190 | $163 |
| 2020 | $0 | $82 | $18–$173 | $114 |
| 2021 | $0 | $74 | $20–$145 | $132 |
| 2022 | $0 | $68 | $28–$179 | $149 |
| 2023 | $0 | $63 | $30–$239 | $160 |
| 2024 | $73 | $73 | $38–$190 | $164 |
| 2025 | $28 | $133 | $46–$264 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 27 drugsPart D claims
1,927
Drug cost
$101,023
Branded share of claims
54.8%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | Brand | 652 | $41,258 | |
| Belbuca Buprenorphine Hcl | Brand | 26 | $21,339 | |
| Zubsolv Buprenorphine Hcl/Naloxone Hcl | Brand | 52 | $9,429 | |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | Brand | 30 | $8,958 | |
| Oxycodone Hcl | Generic | 241 | $3,966 | |
| Oxycontin Oxycodone Hcl | Brand | 13 | $3,916 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 154 | $2,884 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 55 | $1,067 | |
| Diclofenac Sodium | Generic | 31 | $938 | |
| Modafinil | Generic | 24 | $846 |
The 10 drugs with the highest cost, of 27 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 28 billing codesPaid by Medicare
$72,899
Medicare patients
59
Services billed
6,895
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Arthritis | 75% | |
| High blood pressure | 69% | |
| Diabetes | 36% | |
| COPD | 29% | |
| Depression | 27% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, methylprednisolone acetate, 1 mg J1010 | Office | 39 | 5,881 | $610 |
| Injection, methylprednisolone acetate, 40 mg J1030 | Office | 36 | 70 | $337 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 | Office | 23 | 159 | $16 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Addiction Medicine in Pennsylvania
Carol Ludolph
Addiction Medicine · Huntingdon Valley, PA
Athos Cerrato
Addiction Medicine · Havertown, PA
Haley Guzzo
Addiction Medicine · Allentown, PA
Gurpreet Mundi
Addiction Medicine · Philadelphia, PA
Ashok Padhiar
Addiction Medicine · Johnstown, PA
Ming Wang
Addiction Medicine · Wernersville, PA
Related records
Addiction Medicine in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Addiction Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.